RHOEN-KLINIKUM AG/ DE0007042301 /
| 2024-09-09 10:35:57 AM | Chg. -3.10 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 8.60EUR | -26.50% | 30 Turnover: 258 |
-Bid Size: - | -Ask Size: - | 843.42 mill.EUR | - | 21.72 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 0.58 EUR | 52.63% |
| EPS Diluted: | - EUR | 52.63% |
| Revenues per Share: | 22.02 EUR | 1.93% |
| Book Value per Share: | 18.70 EUR | 2.31% |
| Cash Flow per Share: | 1.63 EUR | 80.76% |
| Dividend per Share: | - EUR | - |
| Total | in mill. | |
| Revenues: | 1,473.98 EUR | 1.93% |
| Net Income: | 38.71 EUR | 53.96% |
| Operating Cash Flow: | 109.00 EUR | - |
| Cash and Cash Equivalents: | 206.04 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 21.72 | 17.24 |
| P/S Ratio: | 0.57 | 0.45 |
| P/BV ratio: | 0.67 | 0.53 |
| P/CF Ratio: | 7.74 | 6.14 |
| PEG: | 0.41 | 0.33 |
| Earnings Yield: | 4.60% | 5.80% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 843.42 mill. EUR | 669.38 mill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 60,154.3914 EUR | 47,741.5805 EUR |
| Shares Outstanding: | 66.94 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 2.74% |
| Net Profit Margin: | 2.63% |
| Return on Equity: | 3.09% |
| Return on Assets: | 2.19% |
Financial Strength
| Liquidity I / Cash Ratio: | 61.42% |
| Liquidity II / Quick Ratio: | 129.84% |
| Liquidity III / Current Ratio: | 235.25% |
| Debt / Equity Ratio: | 41.41% |
| Dynam. Debt / Equity Ratio: | 475.67% |
Efficiency
| Employees: | 14,021 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 105,126.52 EUR |
| Net Income / Employee: | 2,761.00 EUR |
| Total Assets / Employee: | 126,276.59 EUR |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
